Chemtrade Logistics Income Fund (CGIFF) Q2 2025 Earnings Call Transcript

Chemtrade Logistics Income Fund reported robust Q2 2025 financial results, with revenue increasing 11% and EBITDA rising 20% year-over-year, largely driven by its Electrochemicals segment and successful mitigation of higher sulfur costs. Reflecting this strong performance, the company raised its full-year 2025 Adjusted EBITDA guidance to $475 million-$500 million, a 10% increase from its initial midpoint, setting up 2025 to be its second-highest EBITDA year. Strategically, Chemtrade announced the acquisition of Polytec for $150 million (approximately 6.5x LTM Adj. EBITDA), expanding its water treatment solutions, and affirmed its commitment to unitholder value through a new Normal Course Issuer Bid and the planned redemption of its 2026 convertible debentures.

Analysis

Chemtrade Logistics Income Fund (CGIFF) reported a robust second quarter for 2025, marked by significant year-over-year growth and strategic advancements. Revenue increased 11% and adjusted EBITDA rose 20%, driven primarily by strong performance in the Electrochemicals (EC) segment. Excluding the impact of a weaker Canadian dollar and a prior-year maintenance turnaround, underlying EBITDA still grew 2%. The EC segment's EBITDA grew 8% on an adjusted basis, benefiting from higher realized caustic soda pricing, with MECU netbacks up approximately $1.65 year-over-year. This strength offset softness in chlorine and a $28.4 million non-cash impairment from the permanent closure of the Prince George sodium chlorate facility, a move aimed at cost consolidation. The Sulfur and Water Chemicals (SWC) segment demonstrated resilience, with revenue up 12% (ex-FX), successfully mitigating a near tripling of sulfur input costs through price increases and risk-sharing agreements, although EBITDA declined 3% (ex-FX) due to margin pressure and maintenance. Strategically, the company announced the acquisition of Polytec, a water treatment solutions provider, for USD 150 million at an approximate 6.5x LTM EBITDA multiple, advancing its 'Vision 2030' growth plan. This move is supported by a strong balance sheet, with net debt-to-EBITDA at 2.0x. Reflecting this operational momentum, Chemtrade raised its full-year 2025 EBITDA guidance to a range of $475 million to $500 million, a 10% increase at the midpoint, positioning 2025 to be its second-highest EBITDA year on record. Capital allocation remains a key focus, with the announcement of a new Normal Course Issuer Bid for up to 10% of units and a plan to redeem its 2026 convertible debentures, signaling confidence and a commitment to enhancing unitholder returns.

Key Decisions for Investors

• Investors should view the raised 2025 EBITDA guidance of $475-$500 million as a primary valuation anchor, reflecting strong underlying performance and successful management of input cost pressures.
• The acquisition of Polytec at 6.5x EBITDA, financed with debt, expands Chemtrade into higher-margin water treatment solutions; monitor the integration and realization of cross-selling synergies, as these are key to validating the purchase price.
• The commitment to a new 10% NCIB and the redemption of convertible debentures are significant drivers of per-unit value and should be considered alongside the sustainable distribution, which has a very low payout ratio of 27% for the quarter.
• Key risks to monitor include sustained high sulfur costs potentially compressing SWC margins and volatility in caustic soda prices, though current index levels of USD 440 per ton remain a tailwind for the EC segment.